Wilson DG - Search Results

1

Increasing age does not affect time to appropriate therapy in primary prevention ICD/CRT-D: a competing risks analysis.

Wilson DG, Zeljko HM, Leventopoulos G, Nauman A, Sylvester GE, Yue A, Roberts PR, Thomas G, Duncan ER, Roderick PJ, Morgan JM. Wilson DG, et al. Europace. 2017 Feb 1;19(2):275-281. doi: 10.1093/europace/euw034. Europace. 2017. PMID: 28173045

2

Letter to the editor regarding survival in octogenarians undergoing cardiac resynchronization therapy compared to the general population.

Wilson DG, Duncan ER. Wilson DG, et al. Pacing Clin Electrophysiol. 2014 Nov;37(11):1587. doi: 10.1111/pace.12515. Epub 2014 Sep 16. Pacing Clin Electrophysiol. 2014. PMID: 25224740 No abstract available.

3

Personalized subcutaneous implantable cardioverter-defibrillator sensing vectors generated by mathematical rotation increase device eligibility whilst preserving device performance.

Wiles BM, Roberts PR, Allavatam V, Acharyya A, Vemishetty N, ElRefai M, Wilson DG, Maharatna K, Chen H, Morgan JM. Wiles BM, et al. Among authors: wilson dg. Europace. 2022 Sep 1;24(8):1267-1275. doi: 10.1093/europace/euab310. Europace. 2022. PMID: 35022725

4

Strategies to reduce infections during the cardiac implantable electronic device implant: a time to name and shame.

Wilson DG, Yue A, Morgan JM, Roberts PR. Wilson DG, et al. Europace. 2015 Apr;17(4):511-3. doi: 10.1093/europace/euu370. Epub 2015 Jan 8. Europace. 2015. PMID: 25573658 No abstract available.

5

Comment on the article by Barra et al. entitled 'Implantable cardioverter-defibrillators in the elderly: rationale and specific age-related considerations'.

Wilson DG, Zeljko HM, Leventopoulos G, Morgan JM. Wilson DG, et al. Europace. 2015 Sep;17(9):1455-6. doi: 10.1093/europace/euv004. Epub 2015 Apr 2. Europace. 2015. PMID: 25840287 No abstract available.

6

Oversensing and Shock Delivery in the S-ICD: Five Shocks Two Mechanisms.

Wilson D, Yue A, Roberts PR, Morgan JM. Wilson D, et al. Pacing Clin Electrophysiol. 2015 Aug;38(8):1009-13. doi: 10.1111/pace.12532. Epub 2014 Oct 31. Pacing Clin Electrophysiol. 2015. PMID: 25358958 No abstract available.

7

Potential eligibility of congenital heart disease patients for subcutaneous implantable cardioverter-defibrillator based on surface electrocardiogram mapping.

Zeb M, Curzen N, Veldtman G, Yue A, Roberts P, Wilson D, Morgan J. Zeb M, et al. Europace. 2015 Jul;17(7):1059-67. doi: 10.1093/europace/euu375. Epub 2015 Feb 11. Europace. 2015. PMID: 25678600 Clinical Trial.

8

Leadless pacing: The old with the new.

Wilson DG, Yue A, Roberts PR, Morgan JM. Wilson DG, et al. Int J Cardiol. 2016 Jan 15;203:407-8. doi: 10.1016/j.ijcard.2015.10.103. Epub 2015 Oct 22. Int J Cardiol. 2016. PMID: 26539965 No abstract available.

9

"Leadless" pacing of the left ventricle in adult congenital heart disease.

Wilson DG, Morgan JM, Roberts PR. Wilson DG, et al. Int J Cardiol. 2016 Apr 15;209:96-7. doi: 10.1016/j.ijcard.2016.01.099. Epub 2016 Jan 8. Int J Cardiol. 2016. PMID: 26882193 No abstract available.

10

ECG predictors of T wave oversensing in subcutaneous implantable cardioverter defibrillators.

Wilson DG, Leventigiannis G, Barr C, Morgan JM. Wilson DG, et al. Int J Cardiol. 2016 Oct 1;220:27-31. doi: 10.1016/j.ijcard.2016.06.128. Epub 2016 Jun 23. Int J Cardiol. 2016. PMID: 27372039

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181 results

Search Page

Filters